128 related articles for article (PubMed ID: 9592636)
1. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
[TBL] [Abstract][Full Text] [Related]
2. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
4. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
Koschinsky ML; Marcovina SM
Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
[TBL] [Abstract][Full Text] [Related]
5. Association of serum lipoprotein (a) with hypertension in diabetic patients.
Nasri H
Saudi J Kidney Dis Transpl; 2008 May; 19(3):420-7. PubMed ID: 18445903
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
Tarkun I; Cetinarslan B; Cantürk Z
Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
[TBL] [Abstract][Full Text] [Related]
8. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
[TBL] [Abstract][Full Text] [Related]
9. Serum lipid levels in diabetic Papua New Guineans.
Erasmus RT; Sinha AK; Gena M; Betuela I; Muthaiah AC; Nathaniel K
P N G Med J; 1991 Mar; 34(1):17-21. PubMed ID: 2058298
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) and diabetes mellitus].
Ziegler O; Guerci B; Candiloros H; Drouin P
Diabete Metab; 1995 Apr; 21(2):127-38. PubMed ID: 7621973
[TBL] [Abstract][Full Text] [Related]
11. [Lp(a) serum concentrations in diabetes mellitus].
Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
[TBL] [Abstract][Full Text] [Related]
12. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
Shi H; Fang J; Yang X; Shen Z; Zhu X
Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
16. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
17. Lack of relationship between Lp(a) particle levels and albumin excretion rate in type 1 diabetic patients.
Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
Diabete Metab; 1994; 20(6):526-31. PubMed ID: 7713275
[TBL] [Abstract][Full Text] [Related]
18. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
19. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
20. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
